Related Experiment Video
Updated: Jul 10, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
[From structural and antigenic features of the rotavirus to the development of the vaccines]
1Service des urgences pédiatriques, Hôpital d'enfants A.-Trousseau, APHP, 26 rue du Dr Netter, 75571 Paris cedex 12, France. nathalie.parez@trs.aphp.fr
Insights
Rotaviruses cause severe diarrhea in young children globally. Vaccination is the most effective way to prevent rotavirus disease, with two safe and efficient vaccines now available.
Area of Science:
- Virology
- Pediatrics
- Immunology
Context:
- Rotaviruses are a leading cause of severe acute diarrhea in children under five worldwide.
- Existing preventive measures against rotavirus transmission are insufficient.
- Vaccination is crucial for controlling the impact of rotavirus infections.
Purpose:
- To review the development and efficacy of newly licensed rotavirus vaccines.
- To compare the strategies behind the development of RotaTeq and Rotarix.
- To highlight the safety and effectiveness of these vaccines in infants.
Summary:
- Two rotavirus vaccines, RotaTeq and Rotarix, have been developed using different strategies and are licensed in the US and Europe.
- Both vaccines have demonstrated safety and efficiency in protecting young infants.
- These vaccines represent a significant advancement in preventing severe rotavirus gastroenteritis.
Impact:
- Provides insights into the latest advancements in rotavirus vaccine technology.
- Supports public health initiatives aimed at reducing childhood mortality and morbidity from rotavirus.
- Informs healthcare providers and policymakers about effective rotavirus prevention strategies.
Abstract:
Rotaviruses are the main etiologic agent of severe acute diarrhoea in children under the age of 5, world-wide. Given that the currently available preventive measures to fight against the transmission of RV disease are not sufficiently effective, vaccination likely represents the only efficacious adapted response to the massive impact of this infection. Two RV vaccines (RotaTeq and Rotarix) have recently been developed and licensed in the United States and in Europe. The development of these two vaccines has followed two different strategies. Despite their differences, these vaccines are both safe and efficient in protecting young infants against severe rotavirus acute gastroenteritis.
More Related Videos
Related Concept Videos
Viral Structure
Vaccine Production
Respiratory Syncytial Virus Disease
Vaccines
Vaccinations
Size and Structure of Viral Genomes

